COMP <GO>
IART vs KIDS // EV/EBITDA & P/E VALUATION
Integra LifeSciences Holdings Corporation (NASDAQ) VS. OrthoPediatrics Corp. (NASDAQ) • 15-METRIC TALLY: IART 1
— KIDS 9
■ METRIC PARITY
LAST: $12.83 (+4.82%) • MKT CAP: $998.2M
valuation
—
LAST: $31.52 (+2.34%) • MKT CAP: $823.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IART VS. KIDS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IART | KIDS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.90% | 73.10% | -22.20 | KIDS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -7.30% | -27.70 | KIDS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.11% | -1.94% | -1.17 | KIDS | /fcf-yield <GO> |
| Operating Margin | -30.20% | -16.60% | -13.60 | KIDS | /operating-margins <GO> |
| Net Profit Margin | -31.60% | -16.80% | -14.80 | KIDS | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 15.40% | -13.90 | KIDS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.64 | 3.00 | -2.36 | KIDS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | KIDS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.8 | 77.8 | -34.99 | KIDS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $998.2M | $823.0M | $175.2M | IART | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IART REV | KIDS REV | IART GROSS % | KIDS GROSS % | IART FCF | KIDS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.64B | $236.3M | 50.9% | 73.1% | -$31.1M | -$16.0M |
| FY 2024 | $1.61B | $204.7M | 54.8% | 72.6% | $25.0M | -$41.3M |
| FY 2023 | $1.54B | $148.7M | — | — | $140.0M | -$27.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IART // BETA —
KIDS // BETA —